Logo

Reaction Biology Wins SBIR Grant for Microarray-Based Kinase Screening

Jun 21, 2005

NEW YORK, June 21 (GenomeWeb News) - Reaction Biology has been awarded a Phase I Small Business Innovation Research grant from the National Institutes of Health to develop its microarray kinase screening technology for testing compounds in nanoliter reactions, the company said today.

 

According to Reaction Biology, the grant funds the use of its DiscoveryDot microarray technology for high-throughput kinase screening.

 

RBC also said that it eventually plans to expand its assay range across the human kinome.

 

The company did not disclose the amount of the award, but an NIH database lists a grant for Reaction Biology, entitled, "Kinome Drug Bioassay Platform," in the amount of $100,000.

Breaking News
The Scan

Long COVID-19 Susceptibility Clues Contained in Blood Plasma Proteome

A longitudinal study in eBioMedicine found weeks-long blood plasma proteome shifts after SARS-CoV-2 infection, along with proteomic signatures that appeared to coincide with long Covid risk.

Tibetan Study Finds Adaptive Variant Influencing Skin Pigmentation

With a combination of phenotyping and genetic data, researchers document at PNAS a Tibetan-enriched enhancer variant influencing melanin synthesis and ultraviolet light response.

Domestication Linked to Nervous System Genes in Inbred Mouse Strains

Researchers highlighted more than 300 positively selected genes in domesticated mice, including genes linked to nervous system function or behavior in Genome Biology.

ALS Genetic Testing May Be Informative Across Age Ranges, Study Finds

Researchers in the journal Brain identified clinically actionable variants in a significant subset of older ALS patients, prompting them to point to the potential benefits of broader test use.